Multi-Drug Resistant Pulmonary Tuberculosis

E-ISSN： 1875-6387|2|1|53-57

ISSN： 1573-398X

Source： Current Respiratory Medicine Reviews, Vol.2, Iss.1, 2006-02, pp. : 53-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effective multidrug-resistant tuberculosis treatment

By Nierengarten M.B.

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 118-118

Elsevier

Access to resources Recommend Favorite

Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate

By Gonzalo Ximena Drobniewski Francis

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 366-369

Oxford University Press

Access to resources Recommend Favorite

Novel Compounds and Drugs and Recent Patents in Treating Multidrug- Resistant and Extensively Drug-Resistant Tuberculosis

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 141-156

Bentham Science Publishers

Access to resources Recommend Favorite

The Mechanism by which the Phenothiazine Thioridazine Contributes to Cure Problematic Drug-Resistant Forms of Pulmonary Tuberculosis: Recent Patents for “New Use”

Recent Patents on Anti-Infective Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 206-212

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 110-117

Bentham Science Publishers

Access to resources Recommend Favorite